Fig. 2: Compositional developments along the assembly of the microbiota in the neovagina in MRKH patients. | Nature Communications

Fig. 2: Compositional developments along the assembly of the microbiota in the neovagina in MRKH patients.

From: Insights into the assembly of the neovaginal microbiota in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome patients

Fig. 2

Overall composition of the vaginal microbiota in MRKH women at four stages, including PRE (a), P14D (b), P90D (c), and P2/4Y (d), premenopausal women (H_R) (e) and postmenopausal women (H_M) (f). g The distribution of the vagitypes in MRKH patients at different time-points. Vagitype was assigned according to the species with the highest relative abundance in each vaginal sample. If the maximal relative abundance was less than 30%, the type was defined as ‘Diverse’49. Circles are scaled according to the number of patients for the given vagitype at the given time-point. Intra- and inter-individual Bray–Curtis dissimilarities in the vaginal microbiota of MRKH patients between adjacent time points (h) and between PRE and different post-surgery time-points (i). p, Wilcoxon rank-sum test. Box plot elements include: Centerline for median, box limits for upper and lower quartiles; whiskers indicate 1.5× interquartile range; and points for outliers.

Back to article page